首页 › 基金 › PenderFund Capital Management Ltd. › ESPR
PenderFund Capital Management Ltd. 对 ESPR 的持仓历史
ESPERION THERAPEUTICS INC NE
PenderFund Capital Management Ltd. 在 Q2 2026 的 13F 申报中披露持有 ESPR(ESPERION THERAPEUTICS INC NE)3,884,508 股,市值约 US$12.3M,约占其申报组合的 2.04%,在其申报持仓中市值排名第 16 位。 PenderFund Capital Management Ltd. 最近 12 个申报季度中有 11 个季度披露了 ESPR 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
PenderFund Capital Management Ltd. 对 ESPR 的持仓演变
PenderFund Capital Management Ltd. 于 Q3 2023 首次披露 ESPR 持仓:41,029,000 股(约 US$29.8M)。 该持仓在 Q3 2024 达到峰值 40,429,000 股,市值约 US$52.9M。 在 11 次申报中,PenderFund Capital Management Ltd. 2 次增持、3 次减持、4 次保持不变。 最近一期申报(Q2 2026)显示持股 3,884,508 股、市值约 US$12.3M。 持仓曾出现大幅变动:Q2 2025 增持约 223%、Q3 2025 减持约 69%、Q4 2025 增持约 46%。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 41.03M | $29.83M | 新进 |
| Q4 2023 | 41.03M | $32.54M | 持有 |
| Q1 2024 | 40.43M | $46.69M | 减持 |
| Q2 2024 | 40.43M | $51.86M | 持有 |
| Q3 2024 | 40.43M | $52.94M | 持有 |
| Q1 2025 | 3.00M | $196.82K | 新进 |
| Q2 2025 | 9.68M | $9.53M | 增持 |
| Q3 2025 | 3.00M | $3.04M | 减持 |
| Q4 2025 | 4.39M | $16.25M | 增持 |
| Q1 2026 | 3.89M | $10.66M | 减持 |
| Q2 2026 | 3.88M | $12.28M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ESPR 与 13F 数据
ESPR(ESPERION THERAPEUTICS INC NE)的行业分类暂缺。我们追踪的基金中还有 40 只申报持有 ESPR,申报仓位最大的包括:GLAZER CAPITAL, LLC (US$70.8M), ODDO BHF ASSET MANAGEMENT SAS (US$15.8M), Beryl Capital Management LLC (US$14.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ESPR 的基金
- GLAZER CAPITAL, LLC 22.42M 股 · $70.84M · Q2 2026
- ODDO BHF ASSET MANAGEMENT SAS 5.00M 股 · $15.80M · Q2 2026
- Beryl Capital Management LLC 4.43M 股 · $14.00M · Q2 2026
- PSquared Asset Management AG 3.30M 股 · $10.43M · Q2 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 2.96M 股 · $9.34M · Q2 2026
- TIG Advisors, LLC 2.59M 股 · $8.18M · Q2 2026
- GABELLI & Co INVESTMENT ADVISERS, INC. 2.32M 股 · $7.32M · Q2 2026
- GARDNER LEWIS ASSET MANAGEMENT L P 1.37M 股 · $4.31M · Q2 2026
更多关于 PenderFund Capital Management Ltd.
常见问题
How long has PenderFund Capital Management Ltd. held ESPR?
PenderFund Capital Management Ltd. has disclosed ESPR holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is PenderFund Capital Management Ltd.'s current position in ESPR?
As of Q2 2026, PenderFund Capital Management Ltd. holds 3.88M shares of ESPR (ESPERION THERAPEUTICS INC NE), valued at $12.28M, representing 2.04% of its reported portfolio and ranking #16.
Has PenderFund Capital Management Ltd. been buying or selling ESPR?
In the latest 13F filing (Q2 2026), PenderFund Capital Management Ltd. held unchanged its position in ESPR. The position peaked in Q3 2024 at 40.43M shares.
Which other funds hold ESPR?
Other major institutional holders of ESPR include GLAZER CAPITAL, LLC, ODDO BHF ASSET MANAGEMENT SAS, Beryl Capital Management LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.